DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Posição atual:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

Varian completes acquisition of Cancer Treatment Services International

Varian to deliver six technical presentations at ICCR

Shandong Cancer Hospital proton center joins FlashForward Consortium for flash proton therapy research

Varian Medical Systems presents latest innovations in radiotherapy at DEGRO 25

Merit Medical awarded interventional fluid management agreement with Premier

RaySearch to exhibit the latest news for particle therapy at PTCOG 58

Varian announces acquisitions of Endocare and Alicon

Flash irradiation delivered in a IBA ProteusONE proton therapy treatment room

Herlev University Hospital treats first patient in Denmark on Varian Halcyon system

Varian to host FlashForward Consortium meeting at PTCOG58

NRG Oncology awarded NCI funding for next six years, receives 'exceptional' score

Press releases may be edited for formatting or style
NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group conducting practice-changing clinical and translational research, has been awarded funding of over $95 Million by the NCI for the next six years to continue its work as a lead protocol organization (LPO) program. During the peer review grant renewal process, NRG Oncology received the "exceptional" score of 16.

"Our organization is honored to have received such a strong vote of confidence. Wewill continue to leverage NRG Oncology's network of physicians and nurses, statisticians, patients advocates, and other professionals to conduct meaningful research and through this research improve the lives of those affected by cancer," stated Robert Mannel, MD, an NRG Oncology Group Chair and Director of the Stephenson Cancer Center at the University of Oklahoma.

Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs



"NRG Oncology is moving forward from our exceptional ranking with inspired enthusiasm to continue to evolve our research, structure, and methods to improve outcomes for patients," added Norman Wolmark, MD, an NRG Oncology Group Chair and Medical Director of Breast Surgical Oncology, Cancer Research and Clinical Trials at Allegheny Health Network.

NRG Oncology is refining its strategic plan for the next six years. This plan will address elements necessary for ongoing success, including a focus on increasing accrual to protocols, improving support, guidance, and education pathways for young investigators, and raising awareness of clinical cancer research.

"The NCI asked us to identify our publications in our first four years of operation which materially changed or defined cancer care. We identified over fifty such publications, and this incredible productivity led to our exceptional score. NRG Oncology will build on this success to drive even greater progress and innovation over the next six years," noted Dr. Walter J. Curran Jr., MD, FACR, FASCO, an NRG Oncology Group Chair and Director of the Winship Cancer Institute of Emory University.

The six year grant cycle started March 1, 2019.


About NRG Oncology
NRG Oncology conducts practice-changing, multi-institutional clinical and translational research to improve the lives of patients with cancer. Founded in 2012, NRG Oncology is a Pennsylvania-based nonprofit corporation that integrates the research of the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG). The research network seeks to carry out clinical trials with emphases on gender-specific malignancies, including gynecologic, breast, and prostate cancers, and on localized or locally advanced cancers of all types. NRG Oncology's extensive research organization comprises multidisciplinary investigators, including medical oncologists, radiation oncologists, surgeons, physicists, pathologists, and statisticians, and encompasses more than 1,300 research sites located world-wide with predominance in the United States and Canada. NRG Oncology is supported primarily through grants from the National Cancer Institute (NCI) and is one of five research groups in the NCI's National Clinical Trials Network.

Back to HCB News
  Pages: 1

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Aumente a Sua Perceção da Marca
Leilões + Vendas Privadas
Comece
O mais melhor preço
Comprar Equipamento/Peças
Encontre
O preço o mais baixo
Notícia diária
Leia
A notícia a mais atrasada
Diretório
Browse tudo
DOTmed Usuários
Ética no DOTmed
Veja o nosso
Programa das éticas
O ouro parte o programa do vendedor
Receba PH
Pedidos
Programa do negociante do serviço do ouro
Receba RFP/PS
Pedidos
Fornecedores de Healthcare
Veja tudo
Ferramentas de HCP
Jobs/Treinamento
Achado/suficiência
Um trabalho
Parts Hunter +EasyPay
Comece as peças
Citações
Recently Certified
Vista recentemente
Usuários certificados
Recently Rated
Vista recentemente
Usuários certificados
Central Rental
Equipamento do aluguel
Para menos
Vender Equipamentos/Peças
Comece
A maioria de dinheiro
Service Technicians Forum
Ajuda do achado
E conselho
Simples RFP
Comece o equipamento
Citações
Mostra de comércio virtual
Serviço do achado
Para o equipamento
O acesso e o uso deste local são sujeitos aos termos e às condições do nosso OBSERVAÇÃO LEGAL & OBSERVAÇÃO DA PRIVACIDADE
Propriedade de e proprietário DOTmeda .com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
TODOS OS DIREITOS RESERVADOS